You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 4, 2024

Claims for Patent: 9,132,071


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,132,071
Title:Compositions containing quaternary ammonium compounds
Abstract: Compositions containing quaternary ammonium compounds in which the nitrogen atom is substituted by at least one alkyl group having at least 12 carbon atoms, where composition includes at least 20% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 14 carbon atoms and more than 5%, preferably more than 7% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 16 carbon atoms. Ophthalmic oil-in-water emulsions containing such compositions, and the ophthalmic emulsions being are useful for eye care or for the treatment of eye conditions.
Inventor(s): Rabinovich-Guilatt; Laura (Kadima, IL), Lambert; Gregory (Chatenay Malabry, FR), Lallemand; Frederic (Fresnes, FR), Philips; Betty (Antony, FR)
Assignee: SANTEN SAS (Evry, FR)
Application Number:12/010,778
Patent Claims: 1. An emulsion, comprising: an aqueous phase comprising water; and 0.0005% to 0.1% by weight of the total emulsion of at least one alkyl (C12-C16) dimethyl- or trimethyl-benzyl ammonium halide, wherein at least 20% by weight of the ammonium halide is a C16-alkyl dimethyl- or trimethyl-benzyl ammonium halide and wherein the emulsion droplets have a zeta potential of at least +14.3 mV, and the emulsion remains stable for at least three months after emulsification.

2. The emulsion according to claim 1, wherein the emulsion is an oil-in-water emulsion.

3. The emulsion according to claim 1, wherein at least 80% by weight of the ammonium halide is a C16-alkyl dimethyl- or trimethyl-benzyl ammonium halide.

4. The emulsion according to claim 1, wherein about 90% by weight of the ammonium halide is a C16-alkyl dimethyl- or trimethyl-benzyl ammonium halide.

5. The emulsion according to claim 1, wherein about 95% by weight of the ammonium halide is a C16-alkyl dimethyl- or trimethyl-benzyl ammonium halide.

6. The emulsion according to claim 1, wherein the alkyl (C12-C16) dimethyl- or trimethyl-benzyl ammonium halide is cetalkonium chloride.

7. The emulsion according to claim 1, comprising about 0.002% to about 0.01% by weight of the at least one alkyl (C12-C16) dimethyl- or trimethyl-benzyl ammonium halide.

8. The emulsion according to claim 1, wherein the emulsion includes an oily phase comprising at least one compound selected from the group consisting of triglycerides, medium chain triglycerides, long chain triglycerides, modified propylene glycol, propylene glycol diester, mineral oil, heavy mineral oil, light mineral oil, vegetable oil, castor oil, olive oil, corn oil, soya oil, peanut oil, cottonseed oil, coconut oil, palm oil, almond oil, and sesame oil.

9. The emulsion according to claim 1, wherein the emulsion includes an oily phase comprising medium chain triglycerides.

10. The emulsion according to claim 1, wherein the emulsion comprises at least one surfactant selected from the group consisting of lecithins, sodium docusate, sodium lauryl sulphate, poloxamers, polyoxyethylene sorbitan fatty acids, polyoxyethylene castor oils derivatives, tyloxapol, and polyoxyethylene alkyl ethers.

11. The emulsion according to claim 1, wherein the emulsion comprises at least one osmotic agent.

12. The emulsion according to claim 1, wherein the emulsion further comprises at least one additional cationic agent.

13. The emulsion according to claim 1, wherein the alkyl (C12-C16) dimethyl- or trimethyl-benzyl ammonium halide is the only cationic agent that is included in the emulsion.

14. The emulsion according to claim 1, wherein the emulsion further comprises an active substance selected from the group consisting of riluzole, fusidic acid, latanoprost, loratadine, tacrolimus, naphazoline and ketanserine.

15. An ophthalmic oil-in-water emulsion, comprising: an aqueous phase comprising water; 0.0005% to 0.1% by weight of the total emulsion of at least one alkyl (C12-C16) dimethyl- or trimethyl-benzyl ammonium halide, wherein at least 20 by weight of the ammonium halide is a C16-alkyl dimethyl- or trimethyl-benzyl ammonium halide; an oily phase; and a surfactant, and wherein emulsion droplets have a zeta potential of at least +14.3 mV, and the emulsion remains stable for at least three months after emulsification.

16. The emulsion according to claim 15, wherein at least 80% by weight of the ammonium halide is a C16-alkyl dimethyl- or trimethyl-benzyl ammonium halide.

17. The emulsion according to claim 15, wherein the alkyl (C12-C16) dimethyl- or trimethyl-benzyl ammonium halide is cetalkonium chloride.

18. The emulsion according to claim 15, wherein the oily phase comprises at least one compound selected from the group consisting of triglycerides, medium chain triglycerides, long chain triglycerides, modified propylene glycol, propylene glycol diester, mineral oil, heavy mineral oil, light mineral oil, vegetable oil, castor oil, olive oil, corn oil, soya oil, peanut oil, cottonseed oil, coconut oil, palm oil, almond oil, and sesame oil.

19. The emulsion according to claim 15, wherein the aqueous phase comprises at least 99.9% water.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.